COEP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Coeptis Therapeutics Holdings Inc (COEP) is not a strong buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The lack of positive financial performance, no recent news catalysts, and neutral trading trends suggest limited upside potential at this time. The technical indicators also do not strongly support a buy decision.
The MACD is positive and expanding, suggesting a slight bullish momentum. However, the RSI is in the neutral zone at 68.74, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock price is nearing resistance levels (R1: 11.792, R2: 12.314), which may limit further upward movement.
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
No recent news or significant trading activity to drive interest in the stock.
In Q4 2025, revenue remained flat YoY at $862,049. Net income declined by 19% YoY to -$1,577,869, and EPS dropped significantly by 69.47% YoY to -$0.29. Gross margin remained at 0%. Overall, the financials show no signs of growth or profitability.
No recent analyst ratings or price target changes available.
